secwatch.observer — SEC 8-K summary
======================================

Issuer:     AdaptHealth Corp. (AHCO)
CIK:        0001725255
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001628280-23-037167
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AdaptHealth Q3 revenue up 6.3% to $804M; net loss $454M on $512M goodwill impairment; cuts FY EBITDA guidance
--------------------------------------------------------------------------------

- Net revenue $804.0M (+6.3% YoY); net loss $454.1M vs prior year income $16.1M due to $511.9M goodwill impairment.
- Adjusted EBITDA $161.2M (+0.6% YoY); YTD cash from ops $325.4M, free cash flow $76.6M.
- FY23 guidance: revenue narrowed to $3.160–3.185B; EBITDA lowered to $630–650M (from $650–680M). Capex 10–12%; FCF 3–4% unchanged.
- Subsequent to quarter-end, repurchased $19.4M of common stock under share repurchase authorization.
- Management cites sleep product growth for record revenue; Humana contract delays weighed on EBITDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725255/000162828023037167/0001628280-23-037167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725255/000162828023037167/ahco-20231107.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-037167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer